![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 24, 2015 8:54:50 PM
Dr. Bosch will be speaking on 19 ePD patients.
I just found a discrepancy between the CUA PR on 8-11-14, which listed 43 events; and the company's corporate slide, to which list 13 suvivors. There can not be both, as together they equal 56 and not 55 patients. I stumbled to it by accident. I was trying to respond to Senti on how many psPD their were from those that event. Instead of using the company PR, I used the corporate slide of survivors.
Dr. Bosch will be speaking on 19 patients. 43 patients have evented, and 12 patients have not.
EVENTED GROUP = 43
ePD = 19/43
non enough vaccine patients= 4/43
psPD = 19/43
SURVIVORS = 12
Considering the corporate CUA slide stated 13 survivors. But that can not have been, unless that slide was created in July, prior to sending the world the 8-11-14 PR
43 events and 13 survivors would have meant 56 patients.But the CUA is only 55 patients, therefore, 1 patient, to which they reference who lifted up the median for the 55, confirms my theory, that the corporate slide they used on survivors, was created in July. And therefore, to the old CUA data of the survival timeline, we can add 7.5 months to bring us current from July to February.
Sept - Dec CUA chart had 13 survivors from 23 to 34.5 months
Feb CUA list data as follows: 12 still alive at up to 42 months; all 12 are past 2 years and more than half are past 30 months
42 - 34.5 = 7.5 months
23 + 7.5 = 30months
42 months is the top,
So if we were to see CUA data in the same format as last year, it would read as follows:
---12 patients have a range from 30 to 42 months survival (and counting) (data as of FEBRUARY).
Quote:
--------------------------------------------------------------------------------
---13 patients have a range from 23 to 34.5 months survival (and counting). This data point remained consistent throughout the last half of the year.
Quote:
--------------------------------------------------------------------------------
12 of the 51 patients (=24%) are still alive at up to 42 months; all 12 are past 2 years and more than half are past 30 months - NW February 9, 2015 Bio CEO Investor Conference
--------------------------------------------------------------------------------
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM